Varaico: Literature-Extracted Genetic Variants

Gene:EGLN1
Variant:p.R371H
Back to variants list

EGLN1

NM_022051.3:p.R371H

Associated Papers

Erythrocytosis-inducing PHD2 mutations implicate biological role for N-terminal prolyl-hydroxylation in HIF1α oxygen-dependent degradation domain.

Taber CC et al.

Elife, 2025

Utility of next-generation sequencing in identifying congenital erythrocytosis in patients with idiopathic erythrocytosis.

Anžej Doma S et al.

Frontiers in Medicine, 2024

Characterization of genetic variants in the EGLN1/PHD2 gene identified in a European collection of patients with erythrocytosis.

Delamare M et al.

Haematologica, 2023

Erythrocytosis associated with EPAS1(HIF2A), EGLN1(PHD2), VHL, EPOR or BPGM mutations: The Mayo Clinic experience.

Gangat N et al.

Haematologica, 2022

Heritable disorders of oxygen sensing.

Semenza GL

American Journal of Medical Genetics. Part A, 2021

Heritable disorders of oxygen sensing.

Semenza GL

American Journal of Medical Genetics. Part A, 2021

The Genomics and Genetics of Oxygen Homeostasis.

Semenza GL

Annual Review of Genomics and Human Genetics, 2020

Studies on the Substrate Selectivity of the Hypoxia-Inducible Factor Prolyl Hydroxylase 2 Catalytic Domain.

Abboud MI et al.

Chembiochem : a European Journal of Chemical Biology, 2018

Advances in understanding the mechanisms of erythropoiesis in homeostasis and disease.

Liang R et al.

British Journal of Haematology, 2016

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases.

Chowdhury R et al.

Nature Communications, 2016

Erythrocytosis due to PHD2 Mutations: A Review of Clinical Presentation, Diagnosis, and Genetics.

Wilson R et al.

Case Reports in Hematology, 2016

Modulation of the Hypoxic Response.

Pugh CW

Advances in Experimental Medicine and Biology, 2016

Hypoxia Pathway Mutations in Pheochromocytomas and Paragangliomas.

Amorim-Pires D et al.

Cytogenetic and Genome Research, 2016

Genetic basis of congenital erythrocytosis: mutation update and online databases.

Bento C et al.

Human Mutation, 2014

The role of PHD2 mutations in the pathogenesis of erythrocytosis.

Gardie B et al.

Hypoxia (auckland, N.z.), 2014

Isolated erythrocytosis: study of 67 patients and identification of three novel germ-line mutations in the prolyl hydroxylase domain protein 2 (PHD2) gene.

Albiero E et al.

Haematologica, 2012

Distinct deregulation of the hypoxia inducible factor by PHD2 mutants identified in germline DNA of patients with polycythemia.

Ladroue C et al.

Haematologica, 2012

HIF pathway mutations and erythrocytosis.

McMullin MF

Expert Review of Hematology, 2010

Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis.

Semenza GL

Blood, 2009

The complete evaluation of erythrocytosis: congenital and acquired.

Patnaik MM et al.

Leukemia, 2009

Biochemical characterization of human prolyl hydroxylase domain protein 2 variants associated with erythrocytosis.

Pappalardi MB et al.

Biochemistry, 2008

Role and regulation of prolyl hydroxylase domain proteins.

Fong GH et al.

Cell Death and Differentiation, 2008

A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove.

Percy MJ et al.

Blood, 2007

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."